The sales value inn the pharmaceutical market over the first 15 days of April 2020 decreased by nearly 14 percent compared to the previous year and by more than 38 percent compared to the same period in March 2020. The most significant drops during the coronavirus epidemic in Poland, i.e., since March 2020, were recorded for OTC drugs, special medical dietary products, and supplements.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
Sales value change in the pharmaceutical market due to the coronavirus (COVID-19) outbreak in Poland from April 2019 to April 2020*, by product category
April 1-15 2019, March 1-15 2020, April 1-15 2020***
Supplementary notes
* Sales value in retail prices (excl. VAT). Presented data relate to sale of products used in treatment, prophylaxis and maintenance categorized and included in the pharmacy data database operated by PEX PharmaSequence (Omnibus). Products are classified according to the registration status.
** Special medical dietary products = dietary products for special medical and nutritional uses.
*** Number of days off in researched periods: April 2019 (4), March 2020 (5), April 2020 (5).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PEX PharmaSequence. (April 16, 2020). Sales value change in the pharmaceutical market due to the coronavirus (COVID-19) outbreak in Poland from April 2019 to April 2020*, by product category [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/1111998/poland-pharmaceutical-sales-drop-due-to-covid-19/
PEX PharmaSequence. "Sales value change in the pharmaceutical market due to the coronavirus (COVID-19) outbreak in Poland from April 2019 to April 2020*, by product category." Chart. April 16, 2020. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/1111998/poland-pharmaceutical-sales-drop-due-to-covid-19/
PEX PharmaSequence. (2020). Sales value change in the pharmaceutical market due to the coronavirus (COVID-19) outbreak in Poland from April 2019 to April 2020*, by product category. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/1111998/poland-pharmaceutical-sales-drop-due-to-covid-19/
PEX PharmaSequence. "Sales Value Change in The Pharmaceutical Market Due to The Coronavirus (Covid-19) Outbreak in Poland from April 2019 to April 2020*, by Product Category." Statista, Statista Inc., 16 Apr 2020, https://www.statista.com/statistics/1111998/poland-pharmaceutical-sales-drop-due-to-covid-19/
PEX PharmaSequence, Sales value change in the pharmaceutical market due to the coronavirus (COVID-19) outbreak in Poland from April 2019 to April 2020*, by product category Statista, https://www.statista.com/statistics/1111998/poland-pharmaceutical-sales-drop-due-to-covid-19/ (last visited December 21, 2024)
Sales value change in the pharmaceutical market due to the coronavirus (COVID-19) outbreak in Poland from April 2019 to April 2020*, by product category [Graph], PEX PharmaSequence, April 16, 2020. [Online]. Available: https://www.statista.com/statistics/1111998/poland-pharmaceutical-sales-drop-due-to-covid-19/
